rs179436

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -14 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_StrongBP6_Moderate

The NM_000218.3(KCNQ1):c.477+4901A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.803 (AC=122,183) in the gnomAD database across 152,096 control chromosomes, including 49,407 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.952. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★).

Frequency

Genomes: 𝑓 0.80 ( 49407 hom., cov: 33)

Consequence

KCNQ1
NM_000218.3 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -1.30

Publications

6 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Jervell and Lange-Nielsen syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • long QT syndrome 1
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • atrial fibrillation, familial, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • short QT syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 2
    Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • familial hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: G2P
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000218.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Benign. The variant received -14 points.

BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BP6
ClinVar 1-star benign — moderate (BP6); ClinVar germline classification: Benign/Likely Benign, 1 star(s).
BA1
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.9523 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000218.3. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ1
NM_000218.3
MANE Select
c.477+4901A>G
intron
N/ANP_000209.2
KCNQ1
NM_001406836.1
c.477+4901A>G
intron
N/ANP_001393765.1
KCNQ1
NM_001406837.1
c.207+4901A>G
intron
N/ANP_001393766.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KCNQ1
ENST00000155840.12
TSL:1 MANE Select
c.477+4901A>G
intron
N/AENSP00000155840.2P51787-1
KCNQ1
ENST00000335475.6
TSL:1
c.96+4901A>G
intron
N/AENSP00000334497.5P51787-2
KCNQ1
ENST00000910997.1
c.477+4901A>G
intron
N/AENSP00000581056.1A0ACI8SIJ2

Frequencies

GnomAD3 genomes
AF:
0.803
AC:
122078
AN:
151978
Hom.:
49357
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.713
Gnomad AMI
AF:
0.901
Gnomad AMR
AF:
0.850
Gnomad ASJ
AF:
0.765
Gnomad EAS
AF:
0.975
Gnomad SAS
AF:
0.815
Gnomad FIN
AF:
0.847
Gnomad MID
AF:
0.772
Gnomad NFE
AF:
0.828
Gnomad OTH
AF:
0.802
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.803
AC:
122183
AN:
152096
Hom.:
49407
Cov.:
33
AF XY:
0.807
AC XY:
60023
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.714
AC:
29593
AN:
41458
American (AMR)
AF:
0.850
AC:
13006
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.765
AC:
2652
AN:
3466
East Asian (EAS)
AF:
0.975
AC:
4997
AN:
5126
South Asian (SAS)
AF:
0.815
AC:
3932
AN:
4824
European-Finnish (FIN)
AF:
0.847
AC:
8987
AN:
10606
Middle Eastern (MID)
AF:
0.765
AC:
225
AN:
294
European-Non Finnish (NFE)
AF:
0.828
AC:
56276
AN:
68002
Other (OTH)
AF:
0.804
AC:
1695
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1252
2503
3755
5006
6258
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
874
1748
2622
3496
4370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.817
Hom.:
64509
Bravo
AF:
0.801
Asia WGS
AF:
0.903
AC:
3138
AN:
3478

Local populations

ToMMo 61KJPN (+60KJPN MNV)
AF:
0.993
AC:
121815
AN:
122669
Turkish Variome
AF:
0.780
AC:
1206
AN:
1546
Hom.:
477
WBBC (Westlake BioBank for Chinese) pilot
AF:
0.969
AC:
8685
AN:
8960
Hom.:
4213
ABraOM SABE-WGS-1171
AF:
0.811
AC:
1900
AN:
2342
Hom.:
783

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Long QT syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
0.36
DANN
Benign
0.67
PhyloP100
-1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.